North America is expected to hold a dominant position in the global Targeted Cancer Therapies Market

Targeted cancer therapy is a concept that has come to light in recent times due to the emergence of novel drug concepts. It intends to treat a disease process through the manipulation of one or more target organ systems, which is part of the adaptive immune system. The concept is based on the recognition that all cancers are intimately connected with the genetic architecture of the human body. Therefore, all attempts to destroy cancer cells are accompanied by approaches that are in some way aimed at altering the genetic factors responsible for the growth of cancer cells. For example, it is generally agreed that cancer of the prostate can be effectively eliminated if the DNA of the sebaceous glands of the animal is manipulated.

North America is expected to hold a dominant position in the global Targeted Cancer Therapies Market in the near future and this is accredited to the high prevalence of cancer such as breast cancer, lung cancer, colorectal cancer, and gastrointestinal cancer in the region. For instance, according to the American Cancer Society reports nearly 1.7 million new cancer cases are expected to be diagnosed in 2019 in the U.S. Similarly, according to the National Cancer Institute, in 2018, around 1,735,350 new cases of cancer were diagnosed in U.S. and 609,640 people died from the disease.

Read More@ https://bit.ly/3uQwPUe